BINEX (Korea) Top Management
053030 Stock | KRW 16,060 180.00 1.11% |
BINEX employs about 503 people. The company is managed by 23 executives with a total tenure of roughly 140 years, averaging almost 6.0 years of service per executive, having 21.87 employees per reported executive. Analysis of BINEX's management performance can provide insight into the company performance.
Hyeok Lee CEO Chief Executive Officer, Director |
Baek Lee Chairman Chairman of the Board |
BINEX |
BINEX Management Team Effectiveness
The company has return on total asset (ROA) of 0.0286 % which means that it generated a profit of $0.0286 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 8.9611 %, meaning that it generated $8.9611 on every $100 dollars invested by stockholders. BINEX's management efficiency ratios could be used to measure how well BINEX manages its routine affairs as well as how well it operates its assets and liabilities.BINEX Workforce Comparison
BINEX Co is rated second in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 1,759. BINEX totals roughly 503 in number of employees claiming about 29% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08. BINEX Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. BINEX Price Series Summation is a cross summation of BINEX price series and its benchmark/peer.
BINEX Notable Stakeholders
A BINEX stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BINEX often face trade-offs trying to please all of them. BINEX's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BINEX's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Hyeok Lee | Chief Executive Officer, Director | Profile | |
Baek Lee | Chairman of the Board | Profile | |
Du Kim | Vice President Director | Profile | |
Yin Oh | Non-Executive Independent Director | Profile | |
Taizan Kawakami | Director | Profile | |
Shigeki Yamauchi | Director | Profile | |
Myeong Jeon | Director | Profile | |
Takahiro Yoshikawa | Director | Profile | |
Yun Choi | Non-Executive Independent Director | Profile | |
Jun Park | Managing Director | Profile | |
Myeong Lee | Assistant Managing Director | Profile | |
Su Jin | Assistant Managing Director | Profile | |
HyukJong Lee | Managing Director | Profile | |
YoungCheol Son | Head Director | Profile | |
SooYong Jin | Managing Director | Profile | |
ByungIn Lee | Head Director | Profile | |
MyungCheol Lee | Managing Director | Profile | |
DooHyun Kim | VP | Profile | |
Noboru Inaska | Internal Auditor | Profile | |
JungJin Lee | Head Director | Profile | |
JungTak Moon | Chief Officer | Profile | |
JungWon Seo | Head Director | Profile | |
WonSeok Kim | Head Director | Profile |
About BINEX Management Performance
The success or failure of an entity such as BINEX often depends on how effective the management is. BINEX management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BINEX management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BINEX management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company was founded in 1957 and is based in Incheon, South Korea. Binex is traded on Korean Securities Dealers Automated Quotations in South Korea.
Please note, the presentation of BINEX's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BINEX's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of BINEX's management manipulating its earnings.
BINEX Workforce Analysis
Traditionally, organizations such as BINEX use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BINEX within its industry.BINEX Manpower Efficiency
Return on BINEX Manpower
Revenue Per Employee | 267.2M | |
Revenue Per Executive | 5.8B | |
Net Income Per Employee | 37.8M | |
Net Income Per Executive | 827.4M | |
Working Capital Per Employee | 106.7M | |
Working Capital Per Executive | 2.3B |
Complementary Tools for BINEX Stock analysis
When running BINEX's price analysis, check to measure BINEX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BINEX is operating at the current time. Most of BINEX's value examination focuses on studying past and present price action to predict the probability of BINEX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BINEX's price. Additionally, you may evaluate how the addition of BINEX to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |